SCHEMBL29638112

SCHEMBL29638112

Fc1ccc(Nc2nc(SCCN3CCNCC3)nc3ccnn23)cc1Cl

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ MAPKAPK2 P49137 10/20 0.49
▸ CDK2 P24941 8/20 0.44
▸ ROCK2 O75116 1/20 0.41
▸ MAPK9 P45984 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ MAP2K1 Q02750 1/20 0.41
▸ MAPKAPK5 Q8IW41 1/20 0.41
▸ EGFR P00533 3/20 0.39
▸ CHEK2 O96017 1/20 0.39
▸ CDK1 P06493 1/20 0.39
▸ CSNK1D P48730 1/20 0.39
▸ CDK5 Q00535 1/20 0.39
▸ MAPKAPK3 Q16644 1/20 0.39
▸ DPP4 P27487 4/20 0.38
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ ALDH1A1 P00352 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29638113 0.84 EGFR (0.53) EGFR
SCHEMBL29638114 0.82 ERBB2 (0.52) EGFR
SCHEMBL29638104 0.79 MAPKAPK2 (0.45) MAPKAPK2CDK2ROCK2MAPK9GSK3B
SCHEMBL29638121 0.74 ERBB2 (0.52) EGFR
SCHEMBL29638108 0.72 EGFR (0.52) EGFR
SCHEMBL30213858 0.69 EGFR (0.49) MAPK9MAP2K1EGFRCHEK2CSNK1D
SCHEMBL28539842 0.68 AXL (0.48) EGFR
SCHEMBL29638115 0.65 ALDH1A1 (0.35) EGFRDPP4KDM4EALDH1A1
SCHEMBL7855130 0.64 ABL1 (0.51) MAP2K1EGFRCYP1A2ALDH1A1
SCHEMBL30213751 0.64 EGFR (0.49) MAPK9MAP2K1EGFRCHEK2CSNK1D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110950871-B 2-substituted-4-arylamino pyrazolotriazine derivative and application thereof in preparing antitumor drugs 陕西师范大学 2022-05-17 — — CN claimed
CN-110950871-B 2-substituted-4-arylamino pyrazolotriazine derivative and application thereof in preparing antitumor drugs 陕西师范大学 2022-05-17 — — CN disclosed
Send feedback